Neuroendocrine tumors: current changes in the classification, diagnosis and therapy presented in the draft clinical guidelines of the Ministry of Health of the Russian Federation 2019
- Authors: Gorbunova V.A1
-
Affiliations:
- N.N. Blokhin National Medical Research Center of Oncology
- Issue: Vol 26, No 12 (2019)
- Pages: 66-73
- Section: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/312343
- DOI: https://doi.org/10.18565/pharmateca.2019.12.66-73
- ID: 312343
Cite item
Open Access
Access granted
Abstract
Despite the improvement of diagnostic methods and the developed therapeutic algorithms, the problem of diagnosis and treatment of neuroendocrine tumors is extremely relevant both in the world and in the Russian Federation. This year, updates were made to such sections of clinical guidelines as Pathomorphological and Biochemical Diagnostics, Radionuclide Diagnostics, and Drug Treatment of Neuroendocrine Tumors, the essence of which is reflected in this article.
Full Text
About the authors
V. A Gorbunova
N.N. Blokhin National Medical Research Center of Oncology
Email: veragorbounova@mail.ru
MD, Professor 23, Kashirskoye Highway, Moscow 115478, Russian Federation
References
- Dasari A, Shen C., Haiperin D., et al. Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States. JAMA. Oncol. 2017;3(10):1335-42. Doi: W.W01/jamaoncol.2017.0589.
- Yao J.-C, Hassan M., Phan A., et al. One hundred years after «carcinoid»: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol. 2008;26:3063-72. Doi: 10.1200/ JCO.2007.15.4377.
- Ларичева И.В. Подключение и мониторинг регионов РФ для расширения оценки ключевых эпидемиологических параметров распространенности НЭО в РФ. Круглый стол по вопросам диагностики и лечения нейроэндокрин-
- Singh S., Granberg D., Wolin E., et al. PatientReported Burden of a Neuroendocrine Tumor (NET) Diagnosis: Results From the First Global Survey of Patients With NETs. J Global Oncol. 2017;3(1):43-53. Doi: http://dx.doi. org/10.1200/JGO.2015.002980
- th Annual ENETS Conference, 6-8 March 2019. URL: https://www.enets.org/about_enets_ coe.html
- Нейроэндокринные опухоли. Проект клинических рекомендаций МЗ РФ. 2019.
- Liu et al. Impower 133: primary pfs, os and safety in a ph1/3 Study of 1l atezolizumab+carboplatin+ etoposide in Extensive-stage sclc WCLC 2018 Abs PL 02.07. URL: https://wclc2018.iaslc.org/ wp-content/uploads/2018/09/WCLC2018-Abstract-Book_vF-LR-REV-SEPT-25-2018.pdf
- NCCN Clin Pract Guidenl Oncol. SCLC v.1 2019. URL: https://www.nccn.org/store/login/login. aspx?ReturnURL=https://www.nccn.org/ professionals/physician_gls/pdf/sclc.pdf
Supplementary files
